SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Imclone systems (IMCL)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
2515 89 0 IMCL
Emcee:  Deeber Type:  Unmoderated
Introduction Market Data Compact
Over the last week, Imclone Systems has had a nice rise on higher than usual volume. It also crossed the 10 dollar level which has been a point of resistance lately. There has been no news releases correlating with this. I was just wondering if anyone out here has any information or opinions about this.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2515Denial defined… YMI CEO David Allan just said Nimotuzumab is a best-in-class druDewDiligence_on_SI-8/5/2008
2514<i>Feuerstein had some encouraging things to day about YMI some time (at lDewDiligence_on_SI-8/5/2008
2513Feuerstein had some encouraging things to day about YMI some time (at least a yetom pope-8/5/2008
2512Dueling Begins Over Bristol's ImClone Bid Icahn Questions If Suitor Had AcDoc Bones-8/5/2008
2511YMI Reports Bullshit Interim Nimotuzumab Results in Colorectal Cancer: siliconiDewDiligence_on_SI-8/4/2008
2510Once Dumped, ImClone Soars [NYT] By ANDREW POLLACK August 1, 2008 It was one oDoc Bones-8/1/2008
2509After ASCO, Whither ImClone? Adam Feuerstein 06/02/08 - 07:52 AM EDT CHICAGO Doc Bones-6/5/2008
2508Merrill Scenario analysis on Erbitux FLEX data Erbitux FLEX data – scenario atom pope-4/16/2008
2507Good news for imclone. TOKYO, Feb 18 (Reuters) - Merck KGaA (MRCG.DE: Quote, Prkrw-2/18/2008
2506I had some IMCL over nite and sold them at the open - nice, but <b>when witom pope-9/11/2007
2505This may help IMCL a bit tomorrow. Bought some last week as a trade and decided tom pope-9/3/2007
2504Or maybe? RGEN litigation news. biz.yahoo.com Naughty boys! steveSteve Lokness-6/12/2007
2503I assume that's what caused the sell off starting around 11 A.M. The stock htom pope-6/5/2007
2502CRYSTAL study is statsig—barely: investorshub.comDewDiligence_on_SI-6/5/2007
2501Thanks. Here's Merrill: Expenses cut, Erbitux set to rebound 1Q07 EPS of $1tom pope-4/27/2007
2500Executives on the CC suggested that they’re mending fences with BMY.DewDiligence_on_SI-4/27/2007
2499Wonder what kind of angel dust they threw on the analysts at the earnings call -tom pope-4/26/2007
2498Erbitux whiffs in pancreatic cancer. I think this was expected by most, so the tuck-4/10/2007
2497BSNS WIRE) Amgen Discontinues Vectibix(TM) Treatment in PACCE Trial Evaluatig rel4490-3/22/2007
2496ImClone's Next Blockbuster By Adam Feuerstein Senior Writer 3/19/2007 7:16Doc Bones-3/19/2007
2495Erbitux CRYSTAL Study Hits PFS Endpoint in First-Line CRC: investorshub.comDewDiligence_on_SI-1/10/2007
2494Merrill - wish they'd told me this before I lost 30 cents on a short on Fridtom pope-1/8/2007
2493Imclone to disclose the result of a Phase III study before end of week (29.12 ) IRWIN JAMES FRANKEL-1/8/2007
2492One win, one loss for Erbitux: EPIC study fails in second-line CRC, but NCIC stuDewDiligence_on_SI-11/6/2006
2491Analysts React to Icahn at ImClone [WSJ] October 25, 2006 3:45 p.m. Analysts cDoc Bones-10/26/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News